148 related articles for article (PubMed ID: 30548467)
21. Polymyositis following autologous haematopoietic stem cell transplantation.
Hedermann G; Marquart HV; Vissing J
Scand J Rheumatol; 2016 Oct; 45(5):429-31. PubMed ID: 27050436
[No Abstract] [Full Text] [Related]
22. Efficacy of autologous peripheral blood stem cell transplantation in POEMS syndrome with polyneuropathy.
Imai N; Kitamura E; Tachibana T; Konishi T; Suzuki Y; Serizawa M; Okabe T; Fujita H
Intern Med; 2007; 46(3):135-8. PubMed ID: 17268130
[TBL] [Abstract][Full Text] [Related]
23. Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.
Poenisch W; Plötze M; Holzvogt B; Andrea M; Schliwa T; Zehrfeld T; Hammerschmidt D; Schwarz M; Edelmann T; Becker C; Hoffmann FA; Schwarzer A; Kreibich U; Gutsche K; Reifenrath K; Schwarzbach H; Heyn S; Franke GN; Jentzsch M; Leiblein S; Schwind S; Lange T; Vucinic V; AlAli HK; Niederwieser D
J Cancer Res Clin Oncol; 2015 Nov; 141(11):2013-22. PubMed ID: 25976868
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal involvement in POEMS syndrome: a novel clinical manifestation.
Dogan S; Beyazit Y; Shorbagi A; Köklü S; Ustunel S; Guler N; Uner A
Postgrad Med J; 2005 Sep; 81(959):e12. PubMed ID: 16143676
[TBL] [Abstract][Full Text] [Related]
25. Autologous stem cell transplantation in a lymphoma patient with a long history of ankylosing spondylitis.
Jantunen E; Myllykangas-Luosujärvi R; Kaipiainen-Seppänen O; Nousiainen T
Rheumatology (Oxford); 2000 May; 39(5):563-4. PubMed ID: 10852991
[No Abstract] [Full Text] [Related]
26. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome.
Jaccard A; Royer B; Bordessoule D; Brouet JC; Fermand JP
Blood; 2002 Apr; 99(8):3057-9. PubMed ID: 11929800
[TBL] [Abstract][Full Text] [Related]
27. Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome.
Autore F; Innocenti I; Luigetti M; Piccirillo N; Sora F; Chiusolo P; Sica S; Bacigalupo A; Laurenti L
Hematol Oncol; 2018 Apr; 36(2):392-398. PubMed ID: 28913957
[TBL] [Abstract][Full Text] [Related]
28. Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome.
Ohwada C; Nakaseko C; Sakai S; Takeda Y; Abe D; Takeuchi M; Sakaida E; Masuda S; Shimizu N; Cho R; Nishimura M; Kanai K; Misawa S; Kuwabara S
Bone Marrow Transplant; 2009 May; 43(9):739-40. PubMed ID: 19043459
[No Abstract] [Full Text] [Related]
29. Patients with diffuse large B cell lymphoma in partial response or stable disease after first-line R-CHOP: the prognostic value of the absolute lymphocyte count and impact of autologous stem cell transplantation.
Hung MH; Yu YB; Huang YC; Liu HT; Hong YC; Hsiao LT; Liu JH; Gau JP; Chiou TJ; Chen PM; Tzeng CH; Liu CY
Ann Hematol; 2012 Dec; 91(12):1907-15. PubMed ID: 22885989
[TBL] [Abstract][Full Text] [Related]
30. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
[TBL] [Abstract][Full Text] [Related]
32. Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome.
Laurenti L; De Matteis S; Sabatelli M; Conte A; Chiusolo P; Sorà F; Piccirillo N; Za T; Tarnani M; Rossi E; Leone G; Sica S
Leuk Res; 2008 Aug; 32(8):1309-12. PubMed ID: 18207237
[TBL] [Abstract][Full Text] [Related]
33. Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.
Moore S; Peggs K; Thomson K; Lowry L; Ljubic A; Goldstone AH; Linch DC; Ardeshna KM
Br J Haematol; 2012 Jan; 156(1):142-3. PubMed ID: 21848889
[No Abstract] [Full Text] [Related]
34. High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of Lymphoma.
Hyun SY; Cheong JW; Kim SJ; Min YH; Yang DH; Ahn JS; Lee WS; Ryoo HM; Do YR; Lee HS; Lee JH; Oh SY; Suh C; Yhim HY; Kim JS
Biol Blood Marrow Transplant; 2014 Jan; 20(1):73-9. PubMed ID: 24141009
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of POEMS syndrome with lenalidomide and dexamethasone].
Goto A; Iyama S; Sugama Y; Yoshida M; Ibata S; Tatekoshi A; Fujita C; Kikuchi S; Ikeda H; Murase K; Takada K; Kato J; Kobune M
Rinsho Ketsueki; 2019; 60(4):308-313. PubMed ID: 31068561
[TBL] [Abstract][Full Text] [Related]
36. Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12.
Baetz T; Chen BE; Couban S; Tom Kouroukis C; Buckstein R; Kuruvilla J; Howson-Jan K; Szwajcer D; Federico M; Meyer RM; Djurfeldt MS; Hay AE; Shepherd L; Crump M
Leuk Lymphoma; 2017 Jan; 58(1):64-69. PubMed ID: 27266754
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E
Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265
[TBL] [Abstract][Full Text] [Related]
38. CHOP versus CHOP plus ESHAP and high-dose therapy with autologous peripheral blood progenitor cell transplantation for high-intermediate-risk and high-risk aggressive non-Hodgkin's lymphoma.
Intragumtornchai T; Prayoonwiwat W; Numbenjapon T; Assawametha N; O'Charoen R; Swasdikul D
Clin Lymphoma; 2000 Dec; 1(3):219-25. PubMed ID: 11707834
[TBL] [Abstract][Full Text] [Related]
39. [A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma].
Shi YK; Yang S; Han XH; Ma J; Ren HY; Cen XN; Zhou SY; Wang C; Jiang WQ; Huang HQ; Wang JM; Zhu J; Chen H; Han MZ; Huang H; Shen XM; Liu P; He XH
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):592-6. PubMed ID: 20021946
[TBL] [Abstract][Full Text] [Related]
40. 90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward?
Mondello P; Steiner N; Willenbacher W; Arrigo C; Cuzzocrea S; Pitini V; Mian M
Clin Lymphoma Myeloma Leuk; 2016 Feb; 16(2):82-8. PubMed ID: 26702476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]